Class II

Medical Device Recall: A820 myPTM Software Application associated with Medtronic SynchroMed Pump and Infusion System.

Medtronic Neuromodulation · January 9, 2025

Reason for Recall

Product complaints were received describing the A820 myPTM app taking longer than expected for patients to interact with their implantable pump.

Distribution

Worldwide distribution - US Nationwide and the countries of Austria, Belgium, Canary Islands, Czech Republic, France, Germany, Greece, Ireland, Italy, Netherlands, Norway, Portugal, Puerto Rico, Spain, Sweden, Switzerland, United Kingdom.

States Affected

NATIONWIDE

Quantity Affected

4365 units

Source: FDA (openFDA Device Enforcement)

Recall number: Z-1506-2025

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.

Medtronic Neuromodulation Medical Device Recall: A820 myPTM Software Application associated with Medtronic SynchroMed Pump and Infusion System. | SafeCheck